Portman Square Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-166,100
Closed -$3.38M – 256
2024
Q3
$3.38M Hold
166,100
– – 0.13% 195
2024
Q2
$3.75M Hold
166,100
– – 0.13% 184
2024
Q1
$4.36M Sell
166,100
-205,400
-55% -$5.85M 0.12% 161
2023
Q4
$11.7M Sell
371,500
-8,600
-2% -$233K 0.27% 98
2023
Q3
$10.7M Buy
380,100
+174,700
+85% +$6M 0.26% 98
2023
Q2
$7.58M Buy
+205,400
New +$6.27M 0.22% 108

Other funds holding CC

Portman Square Capital's CC Position: Q4 2024 in Review

Portman Square Capital sold out of Chemours (CC) in Q4 2024, closing a stake of 95,838 shares — an estimated $1.86M sold.

Portman Square Capital first reported a position in CC in Q2 2023 and held it in 6 quarters. The position peaked at $1.95M in Q3 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • Portman Square Capital reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • Portman Square Capital sold 95,838 Chemours shares in Q4 2024, an estimated $1.86M.
  • Portman Square Capital first reported a position in Chemours in Q2 2023 and held it in 6 quarters.
  • Portman Square Capital's Chemours position peaked at $1.95M in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Portman Square Capital's 13F filing for Q4 2024, filed 16 Jan 2025.